In a very big deal, estimated to about $4.6 billion, the Japanese company, Daiichi Sankyo has taken over India's largest pharma company, Ranbaxy Laboratories. This deal stands out as an odd man out as India, a fast emerging economy, has been known to acquire foreign companies but this is the exact opposite. A foreign company taking over an Indian one, is surely a goal against the run of play!
The CEO and MD of Ranbaxy Laboratories, Mr. Malvinder Singh, with his family have taken this decision. He retains his role as CEO post-sales and is to become the chairman too. This is the biggest sellout by an Indian promoter to a foreign company.
Let's wait and watch if it brings about any benefits for the Indians.